AAA

Affinity Asset Advisors Portfolio holdings

AUM $676M
1-Year Return 29.75%
This Quarter Return
+36.42%
1 Year Return
+29.75%
3 Year Return
+452.89%
5 Year Return
10 Year Return
AUM
$615M
AUM Growth
+$114M
Cap. Flow
-$23.6M
Cap. Flow %
-3.84%
Top 10 Hldgs %
41%
Holding
112
New
24
Increased
26
Reduced
15
Closed
21
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ALLO icon
76
Allogene Therapeutics
ALLO
$246M
-400,000
Closed -$1.28M
ALNY icon
77
Alnylam Pharmaceuticals
ALNY
$59.4B
0
ANVS icon
78
Annovis Bio
ANVS
$44.8M
0
ARGX icon
79
argenx
ARGX
$45B
-7,500
Closed -$2.85M
ASND icon
80
Ascendis Pharma
ASND
$12.2B
-20,000
Closed -$2.52M
AZN icon
81
AstraZeneca
AZN
$253B
-60,000
Closed -$4.04M
BHVN icon
82
Biohaven
BHVN
$1.71B
-20,866
Closed -$893K
CRSP icon
83
CRISPR Therapeutics
CRSP
$4.81B
0
DVAX icon
84
Dynavax Technologies
DVAX
$1.17B
-300,000
Closed -$4.19M
EYPT icon
85
EyePoint Pharmaceuticals
EYPT
$806M
-109,900
Closed -$2.54M
GH icon
86
Guardant Health
GH
$7.53B
0
CBIO
87
Crescent Biopharma, Inc. Common Stock
CBIO
$189M
0
GPCR icon
88
Structure Therapeutics
GPCR
$1.12B
0
IBRX icon
89
ImmunityBio
IBRX
$2.25B
0
IFRX icon
90
InflaRx
IFRX
$103M
-200,097
Closed -$326K
IRWD icon
91
Ironwood Pharmaceuticals
IRWD
$185M
0
KALV icon
92
KalVista Pharmaceuticals
KALV
$765M
-125,969
Closed -$1.54M
MRNA icon
93
Moderna
MRNA
$9.44B
0
NBIX icon
94
Neurocrine Biosciences
NBIX
$13.7B
-10,000
Closed -$1.32M
NUVB icon
95
Nuvation Bio
NUVB
$1.15B
-250,000
Closed -$378K
PBYI icon
96
Puma Biotechnology
PBYI
$256M
-202,349
Closed -$876K
PEN icon
97
Penumbra
PEN
$10.8B
-7,500
Closed -$1.89M
RAPT icon
98
RAPT Therapeutics
RAPT
$205M
0
RLAY icon
99
Relay Therapeutics
RLAY
$702M
-300,000
Closed -$3.3M
SAVA icon
100
Cassava Sciences
SAVA
$104M
0